ROSEMARIE STAG: Open Payments
NPI 1447588611 · GLOUCESTER CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 18 payments from 9 companies in 2025. Trend: 2023 $195 · 2024 $341 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $92 |
| Novo Nordisk Inc | 2 | $46 |
| PFIZER INC. | 3 | $45 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: PAXLOVID, QULIPTA, VRAYLAR, CAPVAXIVE, XIFAXAN, Wegovy, UBRELVY, REXULTI.
Industry payments across NJ — which companies pay providers there.
